Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
BI-764524 by Boehringer Ingelheim International for Proliferative Diabetic Retinopathy (PDR): Likelihood of Approval
BI-764524 is under clinical development by Boehringer Ingelheim International and currently in Phase II for Proliferative Diabetic Retinopathy (PDR). According...
Data Insights
BI-764524 by Boehringer Ingelheim International for Non-Proliferative Diabetic Retinopathy (NPDR): Likelihood of Approval
BI-764524 is under clinical development by Boehringer Ingelheim International and currently in Phase II for Non-Proliferative Diabetic Retinopathy (NPDR). According...